KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pacific Biosciences Of California (PACB) Depreciation & Amortization - Total (2022 - 2025)

Historic Depreciation & Amortization - Total for Pacific Biosciences Of California (PACB) over the last 4 years, with Q3 2025 value amounting to $2.5 million.

  • Pacific Biosciences Of California's Depreciation & Amortization - Total fell 4130.69% to $2.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.1 million, marking a year-over-year decrease of 592.33%. This contributed to the annual value of $13.8 million for FY2024, which is 2000.0% up from last year.
  • According to the latest figures from Q3 2025, Pacific Biosciences Of California's Depreciation & Amortization - Total is $2.5 million, which was down 4130.69% from $2.7 million recorded in Q2 2025.
  • Pacific Biosciences Of California's 5-year Depreciation & Amortization - Total high stood at $5.1 million for Q1 2025, and its period low was $2.3 million during Q1 2022.
  • For the 4-year period, Pacific Biosciences Of California's Depreciation & Amortization - Total averaged around $3.0 million, with its median value being $2.8 million (2023).
  • Data for Pacific Biosciences Of California's Depreciation & Amortization - Total shows a peak YoY increase of 5836.42% (in 2025) and a maximum YoY decrease of 4130.69% (in 2025) over the last 5 years.
  • Pacific Biosciences Of California's Depreciation & Amortization - Total (Quarter) stood at $2.6 million in 2022, then rose by 17.56% to $3.0 million in 2023, then decreased by 4.81% to $2.9 million in 2024, then decreased by 14.19% to $2.5 million in 2025.
  • Its Depreciation & Amortization - Total was $2.5 million in Q3 2025, compared to $2.7 million in Q2 2025 and $5.1 million in Q1 2025.